Increasing evidence has demonstrated that the activation of heme oxygenase (HO)-1 reduces autophagy stimulated by oxidative stress injury, in which the supraphysiological production of reactive oxygen species (ROS) is detected. However, the potential mechanism underlying this effect remains unclear. The present study aimed to investigate the function of HO-1 activation in the regulation of autophagy in glomerular mesangial cells subjected to H 2 O 2 -induced oxidative stress injury. The results demonstrated that the HO-1 agonist, hemin, reduces the LC3 protein level, which was enhanced by H 2 O 2 treatment. Furthermore, hemin-activated HO-1 may function as a regulator of oxidative stress-induced autophagy in a dose-dependent manner. Pharmacological activation of c-Jun N-terminal kinase (JNK) inhibited the effect of hemin, indicating that the JNK signaling pathway is associated with the mechanism of HO-1 in impeding excessive autophagy. In addition to successfully alleviating H 2 O 2 -induced oxidative stress and cellular apoptosis, hemin-activated HO-1 may provide cytoprotection against rapamycin, a specific autophagy agonist. The present result suggested the inhibitory action of HO-1 in the avoidance of a potentially enhanced linkage between autophagy and apoptosis, particularly in the setting of excessive ROS. Therefore, enhancing the intracellular activity of HO-1 may assist the crosstalk between oxidative stress, autophagy and apoptosis, and represent a novel therapeutic strategy for renal ischemic disease.
Introduction
Previous investigation has demonstrated that heme oxygenase (HO), particularly the stress-responsive isoenzyme HO-1, exhibits vital regulatory functions in renal processes under pathophysiological conditions (1) . Due to its beneficial effects, including oxidative stress relief and the inhibition of cell apoptosis, HO-1 has previously been proposed as a potential therapeutic target for ischemia/reperfusion or hypertension-induced glomerular injuries (2, 3) , and diabetic retinopathy (4) . HO-1 has also been considered a potential biomarker of acute kidney injury (5) . Multiple mechanisms may be involved in the protective effects of activated HO-1 (6) . In a previous study, the effect of HO-1 in autophagy, an apoptosis-associated biological process, was also investigated, and an implication of the comprehensive understanding of the protective mechanisms of HO-1 was provided (7) .
Autophagy has been widely studied in the last decade (8) . The mechanism of autophagy has been elucidated based on pathophysiology to understand human biology and disease (9) (10) (11) . Autophagy must be reconsidered not only as a self-degrading strategy for cell survival, but also as a type of dynamic and systematic re-organization of cellular materials and energy (12) . As such, an appropriate intervention strategy effecting autophagy may direct cellular materials and energy flow to intended processes in order to result in the alleviation of diseases. Therefore, targeting autophagy may be a non-limiting therapeutic strategy for human disease prevention and treatment. However, despite evidence of the cytoprotective effects provided by enhanced autophagy (13) , excessive autophagic flux induces apoptotic damage to cells (14) . This previous finding demonstrates that prudent consideration is required prior to proposing autophagy-driven treatment strategies.
In renal pathology (15) , HO-1 inhibits autophagy in acute kidney injury and functions as an established therapeutic target for renal diseases (3) . However, the regulatory mechanism through which HO-1 inhibits autophagy remains unclear (7) . It is currently recognized that the c-Jun N-terminal kinase (JNK) signaling pathway is important for modulating the crosstalk between oxidative stress and autophagy. This finding explains the co-existence of JNK activation and enlarged autophagic flux observed in the intracellular setting during (17) . Thus, the LC3 II/LC3 I expression ratio was used as a marker of autophagy in the present study (9) . In addition, p38 inhibition affects nuclear translocation of the HO-1 transcription factor, nuclear factor erythroid 2 like 2, by reducing the intracellular accumulation of p62 (18) . Taken together, these previous findings indicate that the JNK signaling pathway is crucial in ROS-induced HO-1 expression. However, it remains unclear whether HO-1-mediated autophagy inhibition is also associated with JNK signaling in cells insulted by excessive ROS, including H 2 O 2 -induced glomerular mesangial cells.
Furthermore, based on the demonstrated effect of HO-1 on the inhibition of ROS-induced autophagy (3), it is also important to identify the function of HO-1 in this setting. Intrinsically, the biological importance of HO-1 remains unclear, however, it may provide oxidative stress relief and simultaneously inhibit autophagy. The present study aimed to determine the function of HO-1 during complex biological processes, including the oxidative stress response, autophagy and apoptosis, and whether application of HO-1 for the prevention and treatment of kidney disease is plausable. or/and drug treatments, a 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay (Sigma-Aldrich) was performed. Briefly, 20 µl MTT solution was added to each well and the cells were incubated for 4 h. Formazan crystals were subsequently dissolved in 150 µl dimethyl sulfoxide. The optical density of the wells was measured at 490 nm (Bio-TEK Epoch; BioTek Instruments, Inc., Winooski, VT, USA).
Materials and methods

Reagents
Caspase-3 activity assay. To assess the activity of caspase-3, the mesangial cells were scraped from the plates in ice-cold phosphate-buffered saline (PBS). The cells were subsequently lysed in 160 µl ice-cold cell lysis buffer (Beyotime Institute of Biotechnology, Haimen, China) for 30 min. The lysates were centrifuged at 13,000 x g for 30 min at 4˚C. The supernatant was used for the subsequent assay. The enzyme activity was determined using a caspase-3 activity assay kit (Beyotime Institute of Biotechnology). The caspase-3 activity was determined by detecting the absorbance of p-nitroanilide at 405 nm with an Epoch microplate reader (BioTek Instruments, Inc.).
Detection of ROS levels. The peroxide-sensitive fluorescent probe, 2',7'-dichlorodihydrofluorescin diacetate (DCHF-DA; Beyotime Institute of Biotechnology), was used to measure intracellular ROS accumulation. The mesangial cells were initially incubated for 45 min at 37˚C in PBS containing 10 µM DCHF-DA to label intracellular ROS, prior to washing with PBS. Fluorescence was then observed when DCFH-DA was intracellularly oxidized to 2' ,7'-dichlorofluorescein (DCF). The fluorescence intensity of DCF was detected by flow cytometry using a BD FACSAria (BD Biosciences, Franklin Lakes, NJ, USA). The excitation and emission wavelengths were set at 488 and 525 nm, respectively. BD CellQuest software (FACSDiva version 2.0; BD Biosciences) was used to assess flow cytometry data.
Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)
. TUNEL staining was performed using an in situ cell death detection kit (Roche Diagnostics GmbH, Mannheim, Germany), according to the manufacturer's protocol. Cells within a field were identified by 4',6-diamidino-2-phenylindole (Sigma-Aldrich) staining and the labeled glomerular mesangial cells were analyzed by confocal microscopy (FV300; Olympus Corporation, Tokyo, Japan). The percentage of apoptotic cells was determined by counting the number of apoptotic TUNEL-positive cells (out of a total of >200 cells in 5 random fields) and dividing by the total number of cells.
Annexin V and propidium iodide (PI) staining assay.
An annexin V/PI apoptosis detection kit (Beijing Biosea Biotechnology Co., Ltd., Beijing, China) was used to stain the cells with annexin V and PI, according to the manufacturer's protocol. The cells were subsequently centrifuged at 1,000 x g for 5 min at 4˚C. The cell pellets were resuspended in binding buffer and treated with 5 µl annexin V for 20 min, then incubated with 10 µl PI for 5 min in the dark. The rate of apoptosis was analyzed by flow cytometry (BD FACSAria; BD Biosciences) using the BD CellQuest software (FACSDiva v 2.0; BD Biosciences).
Western blot analysis. The cells were washed once with ice-cold PBS and lysed in buffer containing 1% protease inhibitor solution (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The protein concentration was determined using a bicinchoninic acid protein assay reagent kit (Bio-Rad Laboratories, Inc.) and cellular proteins were extracted with lysis buffer containing 1% protease inhibitor solution. Next, protein lysates were separated on 15% sodium dodecyl sulfate-polyacrylamide gels and transferred onto polyvinylidene difluoride membranes (Thermo Fisher Scientific, Inc.). The membranes were blocked with 5% non-fat dry milk (Bio-Rad Laboratories, Inc.) in PBS for 2 h at room temperature. The blots were incubated with the rabbit anti-LC3 primary antibody (dilution, 1:200) at 4˚C overnight, followed by incubation with fluorescence-conjugated goat anti-rabbit immunoglobulin G (cat. no. A27033; Invitrogen; Thermo Fisher Scientific, Inc.) at a dilution of 1:10,000 for 1 h at room temperature. The protein bands were quantified using the Odyssey infrared imaging system (LI-COR, Inc., Lincoln, NE, USA).
Immunofluorescence. After 24 h of incubation with or without drugs, the culture media was removed and the cells were fixed in methanol for 5 min at room temperature. The cells were washed with PBS, permeabilized with 0.4% Triton X-100 in PBS for 1 h, blocked with 5% bovine serum albumin (Gibco; Thermo Fisher Scientific, Inc.) for 1 h at room temperature, and incubated with rabbit anti-LC3 primary antibody (1:50) overnight at 4˚C. Subsequently, the cells were re-warmed and incubated in the dark with the goat anti-rabbit AlexaFluor594-conjugated secondary antibody (cat. no. R37117; Molecular Probes; Thermo Fisher Scientific, Inc.) at a dilution of 1:100 for 1 h at room temperature. The samples were washed with PBS and were subsequently mounted onto microscopic slides. The prepared slides were subsequently examined using a laser confocal microscope (Olympus FluoView 300; Olympus Corporation).
Examination of cell ultrastructure by transmission electron microscopy. The cells were incubated with or without drugs for 24 h and were subsequently fixed in 2.5% glutaraldehyde (Beyotime Institute of Biotechnology) overnight at 4˚C. The cells were post-fixed with 1% osmium tetroxide (Sigma-Aldrich) for 2 h, washed in PBS and progressively dehydrated in a 10% graded series of 50 to 100% ethanol and propylene oxide. The blocks, which had been embedded in acrylic resin (Sigma-Aldrich) were cut into ultrathin sections (50 nm) with a microtome and were subsequently stained with saturated uranyl and lead citrate. The cell ultrastructure was examined using an H-7650 transmission electron microscope (Hitachi, Ltd., Tokyo, Japan).
Statistical analysis. The data are expressed as the mean ± the standard error of the mean. Data analysis was performed using one-way analysis of variance followed by Bonferroni's test and Pearson correlation test. P<0.05 was considered to indicate a statistically significant difference. GraphPad Prism software (version 6.0; GraphPad Software, Inc., La Jolla, CA, USA) was used to perform the data analysis.
Results
Activation of HO-1 reverses H 2 O 2 -induced autophagy.
Pathological induction of HO-1 was previously demonstrated to protect against renal injuries caused by ischemic acute renal failure, indicating that HO-1 is involved in renal pathology (20) . In the present study, an in vitro model of H 2 O 2 -induced glomerular mesangial cell injury was established to assess the protective effect of HO-1 activated by hemin, a HO-1 agonist. A concentration of ~125 µM H 2 O 2 was selected, as this concentration induces an appropriate level of cell damage (data not shown). Activation of HO-1 by the agonist hemin was demonstrated to reduce the expression of LC3 compared with H 2 O 2 treatment (P<0.001), which suggested that HO-1 effects H 2 O 2 -induced autophagy. Notably, the effect of hemin on autophagy when the intracellular ROS levels were overloaded was demonstrated to be dose-dependent (Fig. 1A) . The electron microscopy and immunofluorescence results further verified this finding by demonstrating the effects of hemin on the size and quantity of autophagosomes (Fig. 1B and C) . Inhibition of HO-1 by the antagonist, ZnPP, increased autophagy in the mesangial cells stimulated with H 2 O 2 . A previous study demonstrated that activation or inactivation of HO-1 does not alter basal autophagy (21) . The results of the present study indicated that the effect of HO-1 on reducing autophagy may be ROS-dependent in glomerular mesangial cell.
HO-1-modulated autophagy is associated with oxidative stress relief and JNK activit y.
Pre-treatment with 125 µM H 2 O 2 resulted in a significant increase in the levels of ROS in glomerular mesangial cells (P<0.001; Fig. 2A ). The addition of hemin reversed the increase in the ROS level to the basal level compared with H 2 O 2 treatment (P<0.001). However, the addition of ZnPP resulted in no further increase in the ROS level compared with the levels induced by H 2 O 2 . These results suggested that effective free radical scavenging may require sufficient activation of HO-1. The oxidative stress relief following hemin treatment was concentration-dependant, as demonstrated by the detection of ROS intensity (Fig. 2B) . The present study also demonstrated a significant proportional association between attenuated autophagy and oxidative stress relief. This association may be attributed to different degrees of HO-1 activation by hemin (P= 0.0103; Fig. 2C ). This result may indicate a dose-dependent intrinsic link between HO-1-mediated regulation of oxidative stress and autophagy.
The JNK agonist, anisomycin, significantly increased the LC3-II/LC3-I expression ratio in H 2 O 2 -treated glomerular mesangial cells (Fig. 2D) . The stimulation of JNK activity by anisomycin eliminated the effect of hemin on autophagy relief. This finding suggested that the regulatory effect of hemin on LC3 expression is association with JNK signaling, which is a downstream signaling pathway induced by oxidative stress. This result demonstrated the importance of JNK signaling in the hemin-mediated association between attenuated autophagy and oxidative stress relief.
Attenuation of autophagy by hemin protects against H 2 O 2 -induced apoptosis.
The specific autophagy agonist, rapamycin, was used in the present study to further investigate the specific function of activated HO-1 during autophagy in a cellular environment with an excessive release of free radicals. The activation of HO-1 by hemin protected against H 2 O 2 -induced cell apoptosis, as demonstrated by significantly increased cellular viability and downregulated activity of the apoptotic marker, caspase-3, compared with H 2 O 2 -treated glomerular mesangial cells (P<0.001; Fig. 3A and B) . Additionally, TUNEL staining and flow cytometry assays supported these results (Fig. 3C and D) . The present study demonstrated that co-treatment with the autophagy agonist rapamycin, which can induce excessive autophagy, partially counteracted the cytoprotective effect of HO-1. These results demonstrated that hemin attenuates excessive autophagy and provides cytoprotection against H 2 O 2 -induced cell injury via the inhibition of cell apoptosis.
Discussion
Glomerular mesangial cells are crucial for the regulation of glomerular filtration rate (22) and oxidative stress may impair this vital function of mesangial cells (23) . By relieving oxidative stress, HO-1 is considered a potential therapeutic target in ischemic kidney disease (2, 24, 25) . Although the activation of HO-1 protects mesangial cells from oxidative stress-induced injury, the specific mechanism underlying the protective effect of HO-1 remains elusive, particularly regarding cell autophagy (7) . The present study identified the function of HO-1 during oxidative stress and autophagy in mesangial cells stimulated with H 2 O 2 .
It has previously been demonstrated that the overexpression of HO-1 reduces cisplatin-induced excessive autophagy in proximal tubule cells (3) . In accordance with this previous finding, the current results further demonstrated that the pharmacological activation of HO-1 inhibits external oxidative stress-mediated autophagy in glomerular mesangial cells; however the inactivation of HO-1 exacerbates the autophagic response. Taken together, these findings affirm the active modulation of HO-1 during autophagy. The HO-1-induced effect was also demonstrated to be dose-dependant, as HO-1 successfully inhibited the increasing autophagy caused by H 2 O 2 . However, no significant alteration in the basal autophagy level was detected in normal mesangial cells through the pharmacological intervention of HO-1 activity (21) . This implies that the HO-1-mediated control of autophagy may be ROS-dependent. HO-1 is the only endogenous source of carbon monoxide (CO), which is generated by HO-1-catalyzed oxidative breakdown of heme (26) . Generation of CO contributes to the regulation of cellular autophagy by HO-1. It was previously demonstrated that autophagy is activated by CO via ROS generation in the mitochondria, while Mito-TEMPO, a mitochondria-targeting antioxidant, reversed the effect of CO (27) . Taken together, these results suggested that over-activation of HO-1 failed to change the autophagy level under normal conditions in which only low abundance of heme was found, since the content of ROS was low.
HO-1 is one of the major endogenous antioxidants and can reduce the intracellular generation of ROS. As oxidative (28) , the free radical scavenging role of HO-1 activated by hemin may reverse the autophagy activating effect of CO. Previous investigations (3, 29) and the present study confirmed this. The present study demonstrated that the inhibition of autophagy by hemin-activated HO-1 is significantly proportional to the effect of hemin on the scavenging of cellular free radicals. The current findings of HO-1-inhibited autophagy do not conflict with the results of previous studies performed in other types of cell, including hepatocytes and cardiomyocytes (30, 31) . In these previous studies, the induction of HO-1 enhanced, rather than attenuated, autophagy. It was previously proposed that the different intracellular environments of cells from various sources may cause the opposing effects of HO-1 on autophagy. However, further experiments are required to perform this type of cell-based comparison under the same conditions and to clarify the potential mechanisms involved.
Increased levels of ROS alter autophagy in cells (32) . The results of the present study demonstrated that HO-1 is responsible for reducing the association between oxidative stress and autophagy. The HO-1 activation was demonstrated to reverse H 2 O 2 -induced cell injury significantly by exhibiting an effect in the levels of scavenging cellular free radicals and inhibiting autophagy in glomerular mesangial cells. Furthermore, the present study demonstrated that HO-1 may be regulated by JNK signaling. Previous studies 
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have demonstrated that the JNK pathway is one of the major ROS-modulated cell signals (33) and is involved in autophagy regulation (34) . The present study demonstrated that, in addition to inducing the expression of HO-1 (17), JNK signaling may also have important functions in the HO-1-associated crosstalk between oxidative stress and autophagy. The results of the present study supported the findings reported by the previous study (35) . Apoptosis and autophagy are two complex, interlinked processes of cell death and degradation, respectively (36) . The findings of the present study support the function of HO-1 as an important regulator during oxidative stress-induced autophagy and consequential apoptosis (3) . Although self destruction may be used by cells as an important strategy during oxidative stress injury, natural selection applies specific methods that can be used by cells to survive in harsh environments. As an excessive increase in autophagy can harm cells (14) , the successful relief of external ROS injury, the restoration of the autophagy level to the basal level, and the impediment of excessive autophagic flux demonstrate the important and unique functions of HO-1 during oxidative stress-induced autophagy. 
The present findings provided novel insights into the mechanisms underlying the HO-1-induced protection against oxidative stress-induced cell damage. The current results present additional information, which will improve the understanding of the specific functions of HO-1 during the cellular response to external stress.
